An erectile failure drug is available for $2,000 per pill, the largest price increase in nearly two years.
The price increase comes amid rising rates for erectile disorder medications and amid a recent decision by a federal judge to rule that the Drug Enforcement Administration’s market-distorting practice of classifying certain drugs as controlled substances was unlawful.
In August, the FDA released a report stating that the cost of some drugs like Viagra, which is FDA-approved for erecting, erecting-like, and ejaculating erections, rose by as much as 50% since 2010.
That price hike, the report found, has been occurring as the agency began to restrict prescription drug sales.
The drug companies involved, including Pfizer Inc., Johnson & Johnson and Pfizer, are all trying to keep erectile disorders from going unaddressed by the FDA.
The company that makes the drug, Propecia Inc., declined to comment on the price increase, but the FDA said the price change was a result of increased scrutiny of the drug’s marketing.
Drug makers have also fought efforts to keep prices lower.
Pfizer has sued to block an effort by the Centers for Medicare & ; Medicaid Services to limit the price of a drug that treats a rare form of prostate cancer.
The FDA has been under scrutiny over whether the drug could be used to treat people with prostate cancer who can’t afford the full price.
Pfizer has been sued by the American Cancer Society and others over claims that the drug was not prescribed enough.
In June, the company settled a lawsuit by the Society for Women’s Health and Men’s Health for $25 million.
Johnson & .
Johnson > .
and Pfizers declined to discuss their prices.
The Justice Department said on Monday it had opened an investigation into whether the government misused taxpayer funds in order to sell more drugs.
The investigation, which will include the purchase of all drugs and the use of federal funds, is focused on whether the agency violated the antitrust laws by engaging in improper pricing practices, the Justice Department statement said.
It said the investigation “will determine whether government funds were improperly used to promote the sale of controlled substances.”
The investigation will also look into whether Johnson <’ s actions in selling more drugs than the agency was required to, violated the Controlled Substances Act.
The Justice Department also is conducting an investigation of Johnson &cans actions to protect itself from antitrust charges.